Will Immunotherapy Work as Salvage Therapy for Patients with Testicular Germ Cell Tumors?
Published 01 March 2021 It’s now been 3.5 years since I last wrote anything about testicular germ cell tumors and ongoing clinical trials. 1 Although we still cure most men afflicted with this disease, we have not made any major new therapeutic advancements since I wrote that last article. Approximately, 15-20% of patients with metastatic germ cell tumors will relapse following initial chemotherapy. Even in this situation, approximately 50% can still be cured with salvage treatments, ...
Fred Hutchinson Cancer Research Center United States University Of Washington Evan Yu Clinical Research Division Clinical Research Service
Source: urotoday.com